Theriva Biologics, Inc. Convertible Preferred Stock, Shares Issued upon Conversion
Theriva Biologics, Inc. (TOVX) had Convertible Preferred Stock, Shares Issued upon Conversion of 899.68 thousand shares as of 2021-02-28, per its 10-K filed 2023-03-30.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2023-03-30
- 2021-02-28: Convertible Preferred Stock, Shares Issued upon Conversion 899.68K shares; Convertible Preferred Stock, Shares Issued upon Conversion as first filed 9.00M shares.
- 2021-01-31: Convertible Preferred Stock, Shares Issued upon Conversion 899.68K shares; Convertible Preferred Stock, Shares Issued upon Conversion as first filed 9.00M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion | Convertible Preferred Stock, Shares Issued upon Conversion as first filed |
|---|---|---|
| 2021-02-28 | 899.68K shares 10-K · filed 2023-03-30 | 9.00M shares 10-Q · filed 2021-05-05 |
| 2021-01-31 | 899.68K shares 10-K · filed 2023-03-30 | 9.00M shares 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |